The fertility and pregnancy rapid test kits market was valued at $1.5 billion in 2023, and is projected to reach $3.1 billion by 2033, growing at a CAGR of 7.4% from 2024 to 2033.
Fertility and pregnancy rapid test kits are over-the-counter diagnostic tools designed to quickly detect hormones in urine or saliva that indicate a woman's fertility status or pregnancy. These tests provide a convenient and private way for individuals to monitor their reproductive health without the need for a healthcare professional's intervention. Pregnancy test kits detect the presence of human chorionic gonadotropin, a hormone produced during pregnancy, while fertility test kits detect luteinizing hormone or estrogen, which are critical for ovulation.
The global fertility and pregnancy rapid test kits market is witnessing robust growth due to factors such as rise in awareness about reproductive health and the convenience of at-home testing, especially among individuals trying to conceive. In addition, alarming rise in infertility rates due to lifestyle factors and delayed childbearing is driving a greater need for fertility test kits among couples seeking to conceive. According to a study published today by the World Health Organization in 2023, around 17.5% of the adult population experience infertility. The Infertility Statistics 2024 revealed that 48.5 million couples experience infertility globally.
This highlights the urgent need for fertility test kits to help individuals monitor their fertility cycles and make informed decision. Moreover, the market growth is significantly driven by the relatively low cost of fertility and pregnancy rapid test kits makes them an affordable option for individuals seeking to monitor their reproductive health without the expense of frequent doctor visits. Furthermore, the widespread availability of these kits in both physical retail stores and online marketplaces makes them easy for consumers to access, thus contributing to the market growth.
Early detection of pregnancy, especially for women with irregular cycles or those who want to confirm pregnancy quickly, is further augmenting the demand for pregnancy test kits. Despite advancements, some test kits may still provide false positives or false negatives, which significantly hampers the market growth. In addition, rise of other reproductive health technologies, such as digital ovulation trackers or mobile apps that offer more detailed insights, may reduce the demand for traditional test kits, thereby restraining the market growth.
On the contrary, innovations in test kit technology, including greater accuracy, user-friendly designs, and faster results, have expanded the appeal and reliability of these products, which are expected to offer remunerative opportunities for the expansion of the global market during the forecast period. In addition, government initiatives to increase awareness about pregnancy testing as a preventative measure due to rise in burden of unplanned pregnancies and alarming rise in rate of abortion are anticipated to open new avenues for the growth of the market in the coming years. According to a 2022 study published by the World Family Planning, approximately 50% of the women across 41 countries use contraceptives to prevent pregnancy. Among these, 22 countries were from sub-Saharan Africa alone.
The global fertility and pregnancy rapid test kits market is segmented into product, test type, end user, and region. On the basis of the product, the market is bifurcated into pregnancy rapid tests and fertility rapid tests. By test type, it is classified into urine-based test kits and blood-based test kits. Depending on end user, it is divided into hospitals, homecare settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of test type, the urine-based test kits rapid tests segment is anticipated to exhibit the highest growth during the forecast period.
Depending on end user, the homecare settings segment is projected to grow at a notable pace throughout the forecast period.
Region wise, the fertility and pregnancy rapid test kits market is likely to witness strong growth in In North America in the coming years.
Fertility and pregnancy rapid test kits are over-the-counter diagnostic tools designed to quickly detect hormones in urine or saliva that indicate a woman's fertility status or pregnancy. These tests provide a convenient and private way for individuals to monitor their reproductive health without the need for a healthcare professional's intervention. Pregnancy test kits detect the presence of human chorionic gonadotropin, a hormone produced during pregnancy, while fertility test kits detect luteinizing hormone or estrogen, which are critical for ovulation.
The global fertility and pregnancy rapid test kits market is witnessing robust growth due to factors such as rise in awareness about reproductive health and the convenience of at-home testing, especially among individuals trying to conceive. In addition, alarming rise in infertility rates due to lifestyle factors and delayed childbearing is driving a greater need for fertility test kits among couples seeking to conceive. According to a study published today by the World Health Organization in 2023, around 17.5% of the adult population experience infertility. The Infertility Statistics 2024 revealed that 48.5 million couples experience infertility globally.
This highlights the urgent need for fertility test kits to help individuals monitor their fertility cycles and make informed decision. Moreover, the market growth is significantly driven by the relatively low cost of fertility and pregnancy rapid test kits makes them an affordable option for individuals seeking to monitor their reproductive health without the expense of frequent doctor visits. Furthermore, the widespread availability of these kits in both physical retail stores and online marketplaces makes them easy for consumers to access, thus contributing to the market growth.
Early detection of pregnancy, especially for women with irregular cycles or those who want to confirm pregnancy quickly, is further augmenting the demand for pregnancy test kits. Despite advancements, some test kits may still provide false positives or false negatives, which significantly hampers the market growth. In addition, rise of other reproductive health technologies, such as digital ovulation trackers or mobile apps that offer more detailed insights, may reduce the demand for traditional test kits, thereby restraining the market growth.
On the contrary, innovations in test kit technology, including greater accuracy, user-friendly designs, and faster results, have expanded the appeal and reliability of these products, which are expected to offer remunerative opportunities for the expansion of the global market during the forecast period. In addition, government initiatives to increase awareness about pregnancy testing as a preventative measure due to rise in burden of unplanned pregnancies and alarming rise in rate of abortion are anticipated to open new avenues for the growth of the market in the coming years. According to a 2022 study published by the World Family Planning, approximately 50% of the women across 41 countries use contraceptives to prevent pregnancy. Among these, 22 countries were from sub-Saharan Africa alone.
The global fertility and pregnancy rapid test kits market is segmented into product, test type, end user, and region. On the basis of the product, the market is bifurcated into pregnancy rapid tests and fertility rapid tests. By test type, it is classified into urine-based test kits and blood-based test kits. Depending on end user, it is divided into hospitals, homecare settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product, the pregnancy rapid tests segment is expected to dominate the market from 2024 to 2033.On the basis of test type, the urine-based test kits rapid tests segment is anticipated to exhibit the highest growth during the forecast period.
Depending on end user, the homecare settings segment is projected to grow at a notable pace throughout the forecast period.
Region wise, the fertility and pregnancy rapid test kits market is likely to witness strong growth in In North America in the coming years.
Competition Analysis
Competitive analysis and profiles of the major players in the global fertility and pregnancy rapid test kits market include Atlas Medical GmbH, Church & Dwight Co., Inc., Everlywell, Inc., Geratherm Medical AG, QuidelOrtho Corporation, Mylab Discovery Solutions Pvt. Ltd., Salignostics, Abbott, SPD Swiss Precision Diagnostics GmbH, and AdvaCare Pharma. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.Additional benefits you will get with this purchase are:
- Quarterly Update* (with the purchase of an enterprise license)
- 5 additional Company Profiles, pre- or post-purchase, as a free update.
- Free Updated Version (once released) with the purchase of an enterprise user license.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- New Product Development/ Product Matrix of Key Players
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Average Selling Price Analysis / Price Point Analysis
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product
- Pregnancy Rapid Tests
- Fertility Rapid Tests
By Test Type
- Urine-based Test Kits
- Blood-based Test Kits
- Others
By End User
- Hospitals
- Homecare Settings
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Atlas Medical GmbH
- Church & Dwight Co., Inc.
- Everlywell, Inc.
- Geratherm Medical AG
- QuidelOrtho Corporation
- Mylab Discovery Solutions Pvt. Ltd.
- Salignostics
- Abbott
- SPD Swiss Precision Diagnostics GmbH
- AdvaCare Pharma
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY PRODUCT
CHAPTER 5: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY TEST TYPE
CHAPTER 6: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY END USER
CHAPTER 7: FERTILITY AND PREGNANCY RAPID TEST KITS MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
Atlas Medical GmbH- Church & Dwight Co., Inc.
- Geratherm Medical AG
- QuidelOrtho Corporation
- Mylab Discovery Solutions Pvt. Ltd.
- Salignostics
- Abbott
- SPD Swiss Precision Diagnostics GmbH
- AdvaCare Pharma
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 240 |
| Published | November 2024 |
| Forecast Period | 2023 - 2033 |
| Estimated Market Value ( USD | $ 1.5 billion |
| Forecasted Market Value ( USD | $ 3.1 billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 2 |
